English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Amanda Rupp | Jul 17, 2016

New dry eye disease medication gains FDA approval

+ Technology/Innovation
Amanda Rupp | Jul 17, 2016

Health leaders support NeuroLINCS program

+ Community
Amanda Rupp | Jul 17, 2016

Health Subcommittee evaluates U.S. trauma system

+ Regulatory
Amanda Rupp | Jul 17, 2016

Colorado primary care facility benefits from Medicare Advantage

+ Regulatory
Amanda Rupp | Jul 15, 2016

Appropriations bill features important lupus support

+ Regulatory
Amanda Rupp | Jul 15, 2016

Increased Pennsylvania tax on tobacco implemented to generate health changes

+ Regulatory
Amanda Rupp | Jul 15, 2016

House bill adds priorities for heart disease, stroke

+ Community
Amanda Rupp | Jul 15, 2016

NAMI announces Stigmafree Company launch

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 444
  • 445
  • 446
  • 447
  • 448
  • 449
  • 450
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily